What is Vor Biopharma's price / book?

Vor Biopharma (VOR) reported price / book of 1.4× in Q1 2025.

How has Vor Biopharma's price / book changed year-over-year?

Vor Biopharma's price / book increased by 3.7% year-over-year, from 1.3× to 1.4×.

What is the long-term trend for Vor Biopharma's price / book?

Over 2 years (2021 to 2023), Vor Biopharma's price / book has grown at a -28.9% compound annual growth rate (CAGR), from 2× to 1×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Vor Biopharma VOR Price / book

Price / book at other companies

Johnson & JohnsonJNJ

7.3×+2.1×

AmgenAMGN

20.6×-6.3×

Vertex PharmaceuticalsVRTX

5.9×-1.7×

Dianthus TherapeuticsDNTH

3.7×+1.9×

Design Therapeutics, Inc.DSGN

3×+2.0×

Cullinan Therapeutics, Inc.CGEM

1.5×+0.3×

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,594%

Enterprise value$617.68M+5,866%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Calculated from Vor Biopharma’s reported figures.

market cap/total stockholders equity=1.4×

Based on the most recent quarter.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's price / book?: Vor Biopharma (VOR) reported price / book of 1.4× in Q1 2025.
How has Vor Biopharma's price / book changed year-over-year?: Vor Biopharma's price / book increased by 3.7% year-over-year, from 1.3× to 1.4×.
What is the long-term trend for Vor Biopharma's price / book?: Over 2 years (2021 to 2023), Vor Biopharma's price / book has grown at a -28.9% compound annual growth rate (CAGR), from 2× to 1×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.